Press release -
CTC and Immuneed are launching The Preclinical Human Model
Manage risk and build value in early clinical development – A unique approach to integrate preclinical and clinical research.
In a close partnership, Immuneed and CTC Clinical Trial Consultants offer a total solution for the preclinical and clinical characterisation of a drug. Our unique approach provides early safety and effect data for a reliable risk assessment, optimised study design and a potential effect outcome of first-in-human (FIH) trials.
We combine the services of an advanced laboratory for ex-vivo analysis of biotherapeutics with a hospital-based clinical research unit dedicated to early clinical studies. Fresh human blood donated by healthy volunteers and patients circulate in a physiologically relevant test environment - the preclinical human model.
First-in-human trials performed by CTC using Immuneed´s test systems provide best-in-class risk mitigation. The safety of the research subjects always comes first.
Why?
- Obtain information on the mechanism of action and other properties of your candidate drug
- Minimise the risk of first-infusion immunological reactions
- Ideal for drugs lacking a suitable animal model
- Effect measurements already in your FIH trial
- Instant, cost and time effective analysis enabled by the laboratory´s proximity to the clinical research unit
- No roundabouts - all expertise under the same roof
Topics
- Medical research
Categories
- preclinical human model
CTC Clinical Trial Consultants AB is a full-service CRO with focus on clinical conduct. Our mission is to facilitate clinical and translational research by providing our customers with cost-effective advice, conduct and reporting of clinical trials. We have four different departments: Clinic, Clinical Operations, Pharmacovigilance and Biometrics, all supported by independent quality assurance management.
Our head office and Phase 1 units are located in Uppsala comprising 28 beds of which 12 are hospital beds in a first-in-human approved research unit whereas our two professional sites for multicenter studies (SMOs) are found in Uppsala and Linköping. We have our own subject database for recruitment of both healthy volunteers and special patient populations.
CTC was founded in 2011 and has successfully conducted over 200 industry sponsored clinical trials for start-up companies as well as for international pharmaceutical companies and CROs. Our track record includes first-in-human, food effect, drug interaction, bioequivalence, bioavaliability and biosimilar studies, new drug delivery systems, medical device, PET/MR, QT and Phase IIa studies.
